GeneticsInvesting News

Your trusted source for investing success

Genetics

Tag: genetics investing

Genetics Facts for Investors

Genetics Facts for Investors

Punnett squares and phenotypes, chromatids and codominance: genetics, and all of its associated terms, isn’t the easiest field to understand. And yet experts agree: this is the future of medicine.

5 Top Genetics Stocks to Watch

5 Top Genetics Stocks to Watch

From diagnostics to drug development, the genetics industry provides information biotech, pharma and medical device companies need to continue making innovative products. That’s why we’re counting down some significant players in genetics and genomics—those companies that splice and edit their days away, developing technologies and tests that are so key

What Is CRISPR and Why Should Investors Care?

What Is CRISPR and Why Should Investors Care?

CRISPR-Cas9 is revolutionizing gene engineering. And for those keen on the sector, there is ample opportunity to break into this market, thanks to the rise of CRISPR-based biotechs like Editas Medicine or Intellia Therapeutics. But before you buy in, read on. This emerging technology has plenty of potential—but also a

Biogen to Report Third Quarter 2016 Financial Results

Biogen today announced it will report third quarter 2016 financial results on Wednesday, October 26, 2016, before the financial markets open. Following the release of the financials, the Company will host a live webcast where Biogen management will discuss the financial results, at 8:30 am ET.

Cellectis Reports Latest Financial Results

Cellectis S.A., a biopharmaceutical company focused on developing immunotherapies based on gene edited CAR T-cells (UCART), today announced its results for the three-month period ended June 30, 2016 and for the six-month period ended June 30, 2016.

5 February IPOs on the NASDAQ

5 February IPOs on the NASDAQ

This month, investors can expect some new blood to enter the life science market, with five companies — Editas Medicine, BeiGene, Protestasis Therapeutics, AveXis, Cancer Prevention Pharmaceuticals— listing on the NASDAQ.

Enter Your Log In Credentials
This setting should only be used on your home or work computer.

×

Privacy & Legal Policy

Privacy Policy

×
Investing News Network

Send this to a friend

Hi,
I thought you might find this interesting:
What Is Genetics Investing?

URL: https://investingnews.com/daily/life-science-investing/genetics-investing/what-is-genetics-investing/